COR - Cencora: Potential Exists But Ambiguous Valuations And Data Breach Risks Are Concerning

2024-06-30 07:31:30 ET

Summary

• Cencora, Inc. shows potential undervaluation per DCF analysis, but comparable companies (comps) analysis indicates possible overvaluation.
• Cencora operates globally in pharmaceutical distribution and faces stiff competition in a consolidated industry.
• A 2024 cyberattack and ongoing opioid crisis lawsuits pose substantial risks. Additionally, high valuation metrics (P/E, P/B, and EV/EBITDA) indicate potential overvaluation.

Editor's note: Seeking Alpha is proud to welcome Mahesh Chaganti as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » ...

For further details see: